Khushi Patel
PharmD
Khushi Patel is a Pharm.D professional with a strong foundation in clinical pharmacy, patient-centered care, regulatory affairs, and pharmacovigilance, with published work on Brugada syndrome. Her interests include regulatory affairs, pharmacovigilance, guideline integration, multimodal therapy, pharmacogenomics, and antibiogram utilization, with a focus on evidence-based clinical decision-making and medication safety. As a Pharmacally healthcare writer, she translates clinical and scientific evidence into clear, accurate, and clinically relevant healthcare content, while continuously developing her expertise in evolving pharmacy practice.
About Khushi
Khushi Patel (PharmD) is a writer at Pharmacally, with 43 published articles, each checked against primary sources by our editorial team.
Articles by Khushi Patel
Health TidingsFDA Accepts Tabelecleucel Resubmission for EBV-Positive PTLD
Health TidingsZydus, Formycon Advance First Publicly Announced Keytruda Biosimilar into FDA Review
Clinical TrialsAstraZeneca’s Efzimfotase Alfa Misses Endpoint in Hypophosphatasia Trial
Health TidingsDenifanstat Cuts Acne Lesions by 72% at 52 Weeks, With 57% Treatment Success in Extension Trial
Health TidingsFDA Grants Orphan Drug Designation to vTv’ HPPD for Sickle Cell Disease
Clinical TrialsRezdiffra Shows Consistent Response Across MASH Genetic Risk Groups
Health TidingsOkogen Gets CDSCO Authorization to Advance Treyegen for Acute Infectious Conjunctivitis
Clinical TrialsRevolution Medicines Begins Phase 3 RASolute 309 Trial of Daraxonrasib and Zoldonrasib
Health TidingsLUT014 Shows Significant Improvement in EGFR Inhibitor-Induced Acneiform Rash in Phase 2 Trial
A. Musharaf Mohammad
Aabha Dey
Aarti Bhambre
Aasritha Thippavajjala